跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,113 条关于
“HART CVE”
全部
19,113
临床试验
17,644
药物
551
机构
102
资讯
816
去年
Prevencio's AI-Powered Blood Test for Coronary Artery Disease Receives FDA Breakthrough Device Designation
12个月前
Alcon-STAAR Surgical Merger Advances as Hart-Scott-Rodino Waiting Period Expires
去年
Zevra Therapeutics Secures $150M Deal for Rare Pediatric Disease Priority Review Voucher
去年
New Found Gold Intercepts High-Grade Gold at Queensway Project, Newfoundland
去年
Novartis Launches $7 Tender Offer for Regulus Therapeutics with Additional Regulatory Milestone Payment
去年
SpliSense Achieves First Positive Phase 2 Results for Inhaled Antisense Therapy in Cystic Fibrosis
3个月前
SpliSense Secures Up to $13 Million from Cystic Fibrosis Foundation to Advance Phase 2b Study of Inhaled ASO Therapy SPL84
去年
BioNJ and Medidata Collaborate to Tackle Underrepresentation in New Jersey Clinical Trials
前天
SpliSense Initiates Phase 2b Trial of Inhaled ASO SPL84 as Add-On to CFTR Modulators in Cystic Fibrosis
6个月前
DATATRAK and TAILRD Heart Form Strategic Partnership to Advance AI-Driven Cardiovascular Clinical Research
第 1 页,共 82 页
上一页
下一页